Welcome to Specialised Medicine
New: impact of COVID-19 resource hubLatest Article
The impact of COVID-19 on specialised services
September 2020Other Articles
News
Keep up to date with news relevant to specialised medicines and services
NHS England publishes guidance on determining responsibility for NHS payments to providers
NHS England has published Who pays? Determining responsibility for NHS payments to providers. This revised document, which updates and replaces the original guidance published in […]
A risk-stratified approach to planned cancer care during the COVID-19 pandemic
NICE has published A risk-stratified approach to planned cancer care during the COVID-19 pandemic: the Royal Marsden experience. The report describes a review of the planned cancer […]
CAR T-cell therapy for HIV-associated haematological malignancies
A new article has been published advocating the use of chimeric antigen receptor T (CAR T) therapy for the treatment of haematological malignancies in patients with […]
Medicines Corner
Pharmacists from Guy’s and St Thomas’ NHS Foundation Trust focus on some of the key issues and challenges related to the use of specialised medicines
Histology-independent cancer drugs—navigating the uncertainties of innovative treatments
Significant advances in cancer therapy have been made in recent decades. The elucidation of specific aspects of tumour biochemistry and genetics has led to an […]
Gene therapy medicinal products
Gene therapy medicinal products (GTMPs) are advanced therapy medicinal products (ATMPs): medicines for human use that are based on genes, tissues, or cells. They offer […]
Generic HIV treatments permit cost savings, but their implementation can be complex
National spending on specialised services for the treatment of HIV is significant; in 2016/17, it was close to £540 million, of which antiretroviral treatment (ART) […]